Navigation Links
Hiemstra Appoints Robert C. Glines as Director of Business Development
Date:3/3/2008

Team expansion to ensure highest level of quality and customer satisfaction

SAN FRANCISCO, Calif., March 3 /PRNewswire/ -- Hiemstra Product Development, an innovative, product design and development company, serving the life sciences industry, today announced the appointment of Robert C. (Bo) Glines as Director of Business Development. As the company continues to expand and broaden its capabilities, Mr. Glines ensures quality, customized programs for each client.

Mr. Glines joins Hiemstra with over 20 years of technical, marketing, and business savvy from his experiences with life science Fortune 500 companies including Johnson & Johnson, Medtronic and Boston Scientific, and start-ups, such as CardioThoracic Systems (CTSI), Microheart, Inc., and AngioSense, Inc. He was part of the original, early-stage R&D team at CTSI, where he helped invent the platform technologies and continued through the IPO (which was one of the fastest IPO's of any medical device company). Mr. Glines co-founded Microheart, a needle-based drug delivery company, and founded AngioSense, a drug/device biotechnology venture in the field of gene therapy, where he raised an initial $4 million of financing. He has developed innovative medical technologies and worked with companies from inception to mature enterprises in clinical markets such as cardiac surgery, interventional cardiology, electrophysiology, gene therapy and drug delivery. Mr. Glines has 16 issued patents and numerous patent applications pending, and has coauthored several scientific and clinical publications.

"Today in the Med Tech sector, resource expansion is 'red hot!'," claims Glines. "Now with a 13485-certified clean room, our clients can leverage our infrastructure, experienced resources and CER to accelerate development of their products, from napkin sketch to commercialization." With his intimate knowledge of the medical technology sector, Mr. Glines brings a unique, focused vision as the company expands further down the outsourcing value chain.

Doug Hiemstra, President, stated, "Having known Bo for over ten years, as an associate and client, we believe that he is a perfect fit in our rapidly expanding organization. His breadth of clinical and technical knowledge and life sciences experience make him an asset to the Hiemstra team."

About Hiemstra:

Hiemstra Product Development is an innovative medical product design and development company. Founded in 1991, this San Francisco-based firm is built on its unparalleled integration of industrial and mechanical design, with a unique focus on usability and rapid commercialization. Hiemstra's veteran team's experience spans a broad range of clinical areas and applications, and clients include start-ups to Fortune 500 companies. A portfolio and description of services can be found at http://www.hiemstra.com.


'/>"/>
SOURCE Hiemstra Product Development
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... Denmark , Feb. 3, 2016 Ascendis ... biotechnology company that applies its innovative TransCon technology to ... present at an upcoming investor conference.Event:2016 Leerink Partners Global ... NY Date:  , Wednesday, February 10, 2016 Time:  ... www.ascendispharma.com . --> An audio webcast ...
(Date:2/3/2016)... N.J. , Feb. 3, 2016 ... totaling more than $1 million for researchers in ... working on health-related research that demonstrates exciting potential. ... round of funding for the New Jersey Health Foundation ... faculty members at these educational institutions— Princeton University, ...
(Date:2/3/2016)... , ... February 03, 2016 , ... ... a series of potential targets (epitopes) specific to misfolded, propagating strains of Amyloid ... create specific monoclonal antibody therapeutics for Alzheimer’s. , Following on from the first ...
(Date:2/3/2016)... ... February 03, 2016 , ... Resilinc released online ... analyzes nearly 750 unique supply chain notifications and alerts generated by its ... chain risk management practitioners subscribe to the EventWatch service to receive early warnings ...
Breaking Biology Technology:
(Date:1/20/2016)... 20, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce the attainment ... are the result of the company,s laser focus on ... , it,s comprehensive, easy-to-use and highly affordable cloud-based ... Key MedNet growth achievements in 2015 include: ...
(Date:1/13/2016)... , January 13, 2016 /PRNewswire/ ... announced the addition of the  "India ... Estimation & Forecast (2015-2020)"  report ... http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ) has announced the addition ... Identification Market - Estimation & Forecast ...
(Date:1/7/2016)... , Jan. 7, 2016 This BCC Research ... for biometric technologies and devices, identifying newer markets and ... various types of biometric devices. Includes forecast from 2015 ... Identify newer markets and explore the expansion of the ... Examine each type of biometric technology, determine its current ...
Breaking Biology News(10 mins):